Trials / Conditions / Microsatellite Stable Metastatic Colorectal Cancer
Microsatellite Stable Metastatic Colorectal Cancer
5 registered clinical trials studyying Microsatellite Stable Metastatic Colorectal Cancer — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Me NCT06603818 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal NCT06525428 | Fudan University | Phase 2 |
| Recruiting | Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherap NCT06841159 | Fudan University | Phase 2 |
| Recruiting | Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastati NCT05963490 | Fudan University | Phase 2 |
| Active Not Recruiting | A Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastati NCT05167409 | University of Colorado, Denver | Phase 2 |